Bonus BioGroup (XTAE:BONS) FCF Margin %: 0.00% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTAE:BONS Bonus BioGroup Ltd XTAE:BONS
22 GF Score
Price ₪0.27
! 3 Warning Signs
View Full Analysis

What is Bonus BioGroup FCF Margin %?

Bonus BioGroup XTAE:BONS -0.38% 22 FCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates XTAE:BONS with a GF Score™ of 22/100. The stock has 3 warning signs investors should review. Among 952 Biotechnology companies, Bonus BioGroup ranks worse than 105041.91% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Bonus BioGroup's Free Cash Flow for the six months ended in Dec. 2025 was ₪-6.89 Mil. Bonus BioGroup's Revenue for the six months ended in Dec. 2025 was ₪0.00 Mil. Therefore, Bonus BioGroup's FCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Bonus BioGroup's current FCF Yield % is -4.83%.

The historical rank and industry rank for Bonus BioGroup's FCF Margin % or its related term are showing as below:


XTAE:BONS's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -81.28
* Ranked among companies with meaningful FCF Margin % only.

Bonus BioGroup FCF Margin % Related Terms

Bonus BioGroup FCF Margin % Historical Data

* Premium members only.

The historical data trend for Bonus BioGroup's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bonus BioGroup FCF Margin % Chart

Bonus BioGroup Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Bonus BioGroup Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

XTAE:BONS vs VRTX, REGN, RVMD: FCF Margin % Comparison

For the Biotechnology subindustry, Bonus BioGroup's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bonus BioGroup FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bonus BioGroup's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Bonus BioGroup's FCF Margin % falls into.


XTAE:BONS
22GF Score
Bonus BioGroup Ltd XTAE:BONS
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bonus BioGroup FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Bonus BioGroup's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-14.945/0
= %

Bonus BioGroup's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-6.894/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Bonus BioGroup (XTAE:BONS) has a FCF Margin % of 0.00% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Bonus BioGroup and its competitors. According to the industry distribution chart, Bonus BioGroup ranks #999999 out of 952 companies in the Biotechnology industry.
Is Bonus BioGroup's FCF Margin % too high?
Bonus BioGroup's current FCF Margin % is 0.00%. Based on the distribution chart, Bonus BioGroup ranks #999999 out of 952 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Bonus BioGroup has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Bonus BioGroup's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Bonus BioGroup ranks #999999 out of 952 companies for FCF Margin %. This places Bonus BioGroup in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Bonus BioGroup and its competitors. Bonus BioGroup's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bonus BioGroup stock overvalued right now?
Bonus BioGroup (XTAE:BONS) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Bonus BioGroup's overall GF Score™ is 22/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Bonus BioGroup (XTAE:BONS), the current FCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bonus BioGroup Business Description

Other Exchanges BBIXF:USA
Address Matam Advanced, Technology Park, P.O.B 15143, Haifa, ISR, 31905
Bonus BioGroup Ltd is an clinical-stage biotechnology company developing next-generation therapies for a variety of indications in the regenerative medicine field. Its products products, BonoFill and MesenCure.
22GF Score

Get the complete analysis for XTAE:BONS

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₪0.27
Price